International Core
国际核心
基本信息
- 批准号:8531846
- 负责人:
- 金额:$ 12.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-08-01 至 2016-07-31
- 项目状态:已结题
- 来源:
- 关键词:AIDS clinical trial groupAIDS/HIV problemAcquired Immunodeficiency SyndromeAddressAffectAfricaApplications GrantsAreaAttentionAwardBehavioral ResearchBioethicsBiologicalBreathingCentral AmericaChinaClinicalClinical Trials UnitCollaborationsConsultationsCountryDatabasesDemocratic Republic of the CongoDevelopmentEpidemicEthicsFacultyFosteringFundingGovernmentGrantGuatemalaHIVHIV Vaccine Trials NetworkHIV vaccineHuman ResourcesIMPAACTImmunologyIndustryInstitutional Review BoardsInstructionInternationalInvestigator-Initiated ResearchInvestmentsLaboratoriesLeadershipMalawiManuscriptsMedicalMentorsMentorshipMicrobicide Trials NetworkNicaraguaPlayPostdoctoral FellowPreparationPrevalencePreventionProcessProtocols documentationPublic HealthRecruitment ActivityResearchResearch InfrastructureResearch PersonnelResearch TrainingRoleRussiaServicesSiteSouth AfricaSpecimenSpeedStudentsTrainingTraining ProgramsTranslatingUnited StatesUnited States National Institutes of HealthWorkabstractinganticancer researchbasebehavioral/social scienceclinical careclinical infrastructurecohortdensitydesignimprovedinterestpre-doctoralprogramsprotocol developmentrepositoryresearch and developmentsocialsocial science researchsuccesstransmission processworking group
项目摘要
The International Core is designed specifically to support the international research base of UNC, FHl, and
RTI, including collaborating in-country investigators, foster synergy across the Cores and CFARs, and
enhance HIV/AIDS research collaborations in key countries: Malawi, South Africa, the Democratic Republic
of Congo (DRC), China, Russia, and in Central America, Nicaragua and Guatemala. The sheer volume and
density of HIV in our collaborating sites allows research questions to be addressed with speed and efficiency
impossible in places with lower HIV prevalence. A substantial part ofthe UNC CFAR's NIH support for HIV
research comes for work undertaken outside the United States. This has involved leadership roles in the
nternational NIH networks, including HPTN, the International ACTG, the CHAVI (Center for HIV Vaccine
Immunology), Microbicide Trials Network and IMPAACT. UNC's global AIDS programs have led to the
formation of an NIH HIV Clinical Trials Unit (CTU) in Lilongwe, Malawi, widely viewed as one ofthe best and
most productive in the NIH Networks. Investigator-initiated research on HIV clinical care and biological and
social factors related to HIV transmission and prevention of transmission is ongoing in Malawi, South Africa,
China, the DRC, and Russia; research devoted to STD and HIV overlap has been a focus in China. UNC
investigators have participated in virtually all Fogarty research Training Programs including AITRP, the
Fogarty Center for Bioethics in Francophone Africa, the ICORTA-TB/AIDS, and the Fogarty Ellison pre- and
post-doctoral programs. The Core provides: support for basic, clinical, and behavioral/social science
infrastructure and capacity building; training in-country and at UNC in protocol development, IRB, and
regulatory; and consideration of a range of ethical challenges raised by international research collaborations.
The Core has provided leadership in facilitating cross-Core collaborations, mentoring junior investigators,
manuscript and grant preparation for international collaborators, and communicating results from
international research.
国际核心是专门设计来支持国际研究基地,FHI,
RTI,包括合作的国内调查员,促进核心和CFAR之间的协同作用,
加强关键国家的艾滋病毒/艾滋病研究合作:马拉维、南非、民主共和国
刚果、中国、俄罗斯以及中美洲的尼加拉瓜和危地马拉。巨大的体积和
在我们的合作地点,艾滋病毒的密度使研究问题得到快速和有效的解决
在艾滋病毒感染率较低的地方是不可能的。美国国家卫生研究院对艾滋病的支持
研究是在美国境外进行的。这涉及到领导作用,
国际NIH网络,包括HPTN、国际ACTG、CHAVI(HIV疫苗中心
免疫学),杀微生物剂试验网络和IMPAACT。联合国的全球艾滋病项目已经导致
在马拉维的利隆圭成立了NIH HIV临床试验单位(CTU),被广泛认为是最好的,
在NIH网络中最具生产力。由调查人员发起的关于艾滋病毒临床护理和生物及
与艾滋病毒传播和预防传播有关的社会因素正在马拉维、南非
中国、刚果民主共和国和俄罗斯;致力于性病和艾滋病重叠的研究一直是中国的重点。UNC
调查人员几乎参加了所有福格蒂研究培训计划,包括AITRP,
Fogarty非洲法语国家生物伦理学中心,ICORTA结核病/艾滋病,以及Fogarty Ellison预防和治疗中心。
博士后项目。核心提供:支持基础,临床和行为/社会科学
基础设施和能力建设;在方案制定、IRB和
监管;以及考虑国际研究合作提出的一系列伦理挑战。
核心在促进跨核心协作、指导初级调查员、
为国际合作者准备手稿和赠款,并交流来自
国际研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Gail E HENDERSON其他文献
Gail E HENDERSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Gail E HENDERSON', 18)}}的其他基金
Decision Support for Early-Phase HIV Remission Trials
早期艾滋病毒缓解试验的决策支持
- 批准号:
10380763 - 财政年份:2021
- 资助金额:
$ 12.63万 - 项目类别:
Decision Support for Early-Phase HIV Remission Trials
早期艾滋病毒缓解试验的决策支持
- 批准号:
10160205 - 财政年份:2021
- 资助金额:
$ 12.63万 - 项目类别:
Integrating Decision Making Studies into HIV Cure Trials: A real-time longitudinal assessment
将决策研究纳入艾滋病毒治疗试验:实时纵向评估
- 批准号:
9203291 - 财政年份:2016
- 资助金额:
$ 12.63万 - 项目类别:
Integrating Decision Making Studies into HIV Cure Trials: A real-time longitudinal assessment
将决策研究纳入艾滋病毒治疗试验:实时纵向评估
- 批准号:
9297219 - 财政年份:2016
- 资助金额:
$ 12.63万 - 项目类别:
From Specimen to Biobank: Using an Organizational Perspective to Study ELSI Issue
从样本到生物样本库:使用组织视角研究 ELSI 问题
- 批准号:
7984662 - 财政年份:2010
- 资助金额:
$ 12.63万 - 项目类别:
Partnership for Social Science Research on HIV/AIDS in China
中国艾滋病毒/艾滋病社会科学研究伙伴关系
- 批准号:
7500829 - 财政年份:2007
- 资助金额:
$ 12.63万 - 项目类别:














{{item.name}}会员




